RSPO3/SDC-1 Pathway Dysfunction in Alveolar Repair After ARDS in Older Adults

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2025

Study Completion Date

December 30, 2029

Conditions
Acute Respiratory Distress Syndrome (ARDS)Age-related Impaired Alveolar Epithelial Repair
Interventions
PROCEDURE

RSPO3/SDC-1 pathway profiling assay

"Peripheral Blood: 5 mL collected into EDTA tubes; PBMCs isolated within 2 h for RT-qPCR analysis of RSPO3/SDC-1 mRNA and sandwich ELISA quantification of protein levels.~Saliva: 2-3 mL unstimulated saliva naturally expectorated into sterile tubes, kept at 4 °C and processed within 2 h (centrifuged, aliquoted) before -80 °C storage Subcutaneous Fat: 100-200 mg obtained during elective procedures, preserved in RNAlater at 4 °C for 24 h, then frozen at -80 °C 3D Alveolar Organoid Assay: Lung tissue-derived organoids are cultured in Matrigel and treated ex vivo with recombinant RSPO3 or SDC-1 neutralizing antibody; epithelial repair is assessed over 7 days by Ki-67 immunostaining and wound-closure measurement"

PROCEDURE

Blood and Saliva

"Peripheral Blood: 5 mL collected into EDTA tubes; PBMCs isolated within 2 h for RT-qPCR analysis of RSPO3/SDC-1 mRNA and sandwich ELISA quantification of protein levels.~Saliva: 2-3 mL unstimulated saliva naturally expectorated into sterile tubes, kept at 4 °C and processed within 2 h (centrifuged, aliquoted) before -80 °C storage"

Trial Locations (1)

Unknown

Shanghai Xinhua hospital, Shanghai

All Listed Sponsors
lead

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

NCT07129330 - RSPO3/SDC-1 Pathway Dysfunction in Alveolar Repair After ARDS in Older Adults | Biotech Hunter | Biotech Hunter